Resilience


Contract development and manufacturing organization (CDMO) providing end-to-end development and GMP manufacturing for biologics, vaccines, gene and cell therapies. Services include process & analytical development, cell line and master cell bank support, viral vector and cell therapy manufacturing, aseptic fill/finish, tech transfer and scale-up, and integrated testing and data platforms across a network of North American facilities.

Industries

Health Care
Cyber Security
Office Administration
Risk Management
Education
Biopharma
Biotechnology
Life Science
Telecommunications
Pharmaceutical
Pharmaceutical Manufacturing

Nr. of Employees

large (251-1000)

Resilience


Products

Alachua, FL biomanufacturing campus (Building G)

BSL-2 manufacturing and process/analytical development campus with approximately 92,000 sq ft single-use manufacturing space, dedicated utilities, EU grades A–D particulate controls, multiple GMP suites and cold/ultra-cold storage.

Boston process & analytical development and manufacturing facility

Commercially licensed PAD center combining process and analytical development with 10 × 2,000 L drug substance manufacturing capacity for biologics, vaccines, nucleic acids and gene therapy.

Respiratory Resilience®

A dietary supplement designed to support respiratory health, lung health, immune system, healthy levels of inflammation, and provide antioxidant benefits.

NitroGenesis Pro®

NitroGenesis Pro® is a unique nutraceutical complex formulated to support nitric oxide (NO) production within the bloodstream which supports healthy circulation, facilitates ammonia and lactate removal to diminish fatigue, supports immune health, and provides antioxidant protection. It utilizes a branded, patent pending blend of L-citrulline and Setria® glutathione – Kyowa’s Setria® Performance Blend, producing NO twice as effectively and sustaining NO levels twice as long as comparable doses of L-arginine or L-citrulline. It supports healthy circulation and oxygen delivery to muscles, protects muscles from oxidation and moderate lactate dehydrogenase activity during intense exercise, and provides antioxidant protection and immune support.

Nitric Oxide Ultra (capsules) 120's - NXC1

Nitric Oxide Ultra capsules support healthy nitric oxide production, vascular health, and promote healthy blood flow including flow mediated dilation (FMD). Made with high-quality vegan ingredients including CranLoad® cranberry and grape extract, backed by verifiable science.

Pneumotrate®

Pneumotrate® provides raw lung concentrate (from porcine sources) and vitamin A and vitamin C to support lung health and a healthy immune system.

View All Products

Services

Accelerated autologous CAR‑T manufacturing workflow designed to reduce manufacturing duration (example 3-day process) to enable faster clinical access and potential potency improvements.

Scalable viral vector manufacturing service for AAV and lentiviral vectors with reserved GMP batches and accelerated process deployment for clinical trials.

Integrated services covering cell line development, formulation, process development, analytical method development, and early clinical manufacturing to accelerate IND-enabling timelines.

High-dimensional multi-omics and single-cell genomics characterization and QC services to support cell therapy release testing, comparability and process optimization.

End-to-end manufacturing and assay platform for lentiviral-vector-based autologous T-cell therapies providing standardized unit operations, in-house release testing, digital batch records and regulatory support to accelerate clinical readiness.

Aseptic fill/finish, formulation and packaging services with automated isolator-based filling for vials and syringes and supporting quality and regulatory requirements.

Expertise Areas

  • Biologics process and analytical development (PAD)
  • Viral vector (AAV/LVV) process development and manufacturing
  • Cell therapy development and manufacturing
  • Autologous CAR‑T manufacturing and short-cycle processes
  • Show More (6)

Key Technologies

  • Single-use bioreactors (500 L–2,000 L)
  • Continuous/perfusion upstream and continuous downstream processing
  • Closed automated manufacturing systems with in-line monitoring
  • Aseptic isolator-based filling
  • Show More (8)

News & Updates

Exhibiting/attending event (Boston, MA, June 16–19, 2025).

Scheduled event in San Diego, CA (Nov 10–12, 2025).

Discussion of manufacturing cost drivers for cell therapies and technologies to reduce cost of goods sold, including next-generation characterization, automation and short-cycle approaches.

Description of a cloud-hosted lab supply chain tracking and operational data platform built on AWS to improve visibility and operational reliability.

Whitepaper describing a short-cycle CAR‑T manufacturing process intended to shorten conventional production timelines.

Webinar covering fill/finish capabilities and outsourced pharma capacity for sterile drug product manufacturing.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.